IPP Bureau

Granules India received ANDA approval for Sildenafil for oral suspension
Granules India received ANDA approval for Sildenafil for oral suspension

By IPP Bureau - December 06, 2023

The current annual U.S. market for Sildenafil for Oral Suspension is approximately $43 million

Mankind Pharma's PetStar ties up with Ranbir Kapoor and Neetu Kapoor for new campaign
Mankind Pharma's PetStar ties up with Ranbir Kapoor and Neetu Kapoor for new campaign

By IPP Bureau - December 06, 2023

The esteemed duo perfectly embody the brand's core values of family, love, and the special bond we share with our pets

Zydus receives final approval from the USFDA for Ivabradine Tablets
Zydus receives final approval from the USFDA for Ivabradine Tablets

By IPP Bureau - December 06, 2023

Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States

Briefs: Shelter Pharma and GMM Pfaudler
Briefs: Shelter Pharma and GMM Pfaudler

By IPP Bureau - December 06, 2023

GMM Pfaudler US completes acquisition of MixPro

Cupid acquires land parcel near Mumbai
Cupid acquires land parcel near Mumbai

By IPP Bureau - December 05, 2023

The acquisition will enable Cupid Limited to amplify its production capacity by 1.5 times the existing output

Pradeep Chakravarty joins Alembic Pharmaceuticals as Head - Global Quality
Pradeep Chakravarty joins Alembic Pharmaceuticals as Head - Global Quality

By IPP Bureau - December 05, 2023

Prior to joining Alembic, he was working with Lupin Limited for more than 11 years

AstraZeneca discontinues Phase III trials of Stabilizer-CKD and Dialize-Outcomes
AstraZeneca discontinues Phase III trials of Stabilizer-CKD and Dialize-Outcomes

By IPP Bureau - December 05, 2023

STABILIZE-CKD and DIALIZE-Outcomes trials are part of the CRYSTALIZE evidence programme

Roche to acquire Carmot Therapeutics for US$ 2.7 billion
Roche to acquire Carmot Therapeutics for US$ 2.7 billion

By IPP Bureau - December 05, 2023

Carmot Therapeutics’s R&D portfolio of clinical stage incretins has great potential to treat obesity, diabetes and potentially other diseases

PerkinElmer acquires Covaris to create an innovation-led diagnostics platform
PerkinElmer acquires Covaris to create an innovation-led diagnostics platform

By IPP Bureau - December 05, 2023

Covaris is a global leader in the development and deployment of end-to-end solutions for high-throughput genomic and proteomic analysis

Evonik launches Ecohance Soft Baobab oil for natural cosmetic formulations
Evonik launches Ecohance Soft Baobab oil for natural cosmetic formulations

By IPP Bureau - December 04, 2023

High-quality baobab oil sourced in collaboration with UNCCD and the Great Green Wall Initiative

Sulzer launches new biodegradable polymer
Sulzer launches new biodegradable polymer

By IPP Bureau - December 04, 2023

The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates

Ashland launches Perfectyl to rock skin perfection without injection
Ashland launches Perfectyl to rock skin perfection without injection

By IPP Bureau - December 04, 2023

Multi-ethnic innovation helps all complexions appear clearer and more uniform

AstraZeneca Pharma India receives permission from CDSCO to import new drug
AstraZeneca Pharma India receives permission from CDSCO to import new drug

By IPP Bureau - December 04, 2023

The receipt of this permission paves way for the launch of BREZTRI AEROSPHERE in India

India joins Executive Committee of Codex Alimentarius Commission
India joins Executive Committee of Codex Alimentarius Commission

By IPP Bureau - December 03, 2023

India had proposed for setting up the global standards for millets

Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma
Syngene concludes acquisition of biologics manufacturing facility from Stelis Biopharma

By IPP Bureau - December 03, 2023

The acquisition will add 20,000 litres of installed biologics drug substance manufacturing capacity for Syngene

Latest Stories

Interviews

Packaging